Skip to main content

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • PPMI Data Shows Brain Changes Linked to Parkinson's Progression

    PPMI Data Shows Brain Changes Linked to Parkinson's Progression

    Two studies using data from the MJFF-led Parkinson's Progression Markers Initiative point to brain imaging scans that could help advance drug trials.
    Learn more

  • Can Dogs Help Diagnose Parkinson's Disease?

    Can Dogs Help Diagnose Parkinson's Disease?

    A new study was launched to investigate if man's best friend can play a role in PD diagnosis.
    Learn more

  • MJFF Advancing Nilotinib in Parkinson's Clinical Trial

    MJFF Advancing Nilotinib in Parkinson's Clinical Trial

    The FDA has approved a Phase IIa clinical trial to test the safety and tolerability of nilotinib (Tasigna) in PD.
    Learn more

  • Acquisition May Speed PD Therapies to Meet Unmet Needs

    Acquisition May Speed PD Therapies to Meet Unmet Needs

    Biotech acquisition could help speed PD therapeutic development.
    Learn more

  • Parkinson's Protein Blasting Off to Space

    MJFF is partnering to send LRRK2 protein to the International Space Station to grow larger LRRK2 crystals, which can help develop therapies. Michael J. Fox shares a special message on this project.
    Learn more

  • Update on Alpha-synuclein Therapies in Clinical Trials

    Update on Alpha-synuclein Therapies in Clinical Trials

    Five projects targeting alpha-synuclein are in clinical trials with more preparing for testing.
    Learn more

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.